Nonqaba Jacobs, 28, comes from a rural community outside East London; both parents were HIV-positive and she tested positive in 2004. In 2005 she moved to Khayelitsha, near Cape Town, where she found treatment and attitudes towards HIV to be a world away from what she experienced in the Eastern Cape. These days she is doing well, but is worried about her mother, who has gone off her antiretrovirals in favour of “faith healing” at the Christ Embassy church.
Palabra clave ‘treatment’
South Africa’s HIV/AIDS programme has come a long way from the dark days of denialism and deadly treatment delays. Francois Venter, chairman of the country’s bi-annual HIV conference, SA AIDS 2011, gave IRIN/PlusNews five reasons to be happy about the country’s progress:
Genital herpes is a sexually transmitted disease (STD) caused by the herpes simplex viruses type 1 (HSV-1) or type 2 (HSV-2). Most genital herpes is caused by HSV-2. Most individuals have no or only minimal signs or symptoms from HSV-1 or HSV-2 infection. When signs do occur, they typically appear as one or more blisters on or around the genitals or rectum. The blisters break, leaving tender ulcers (sores) that may take two to four weeks to heal the first time they occur. Typically, another outbreak can appear weeks or months after the first, but it almost always is less severe and shorter than the first outbreak. Although the infection can stay in the body indefinitely, the number of outbreaks tends to decrease over a period of years.
The discovery of a near-perfect way to halt sexual transmission of the AIDS virus has the potential to change the way international agencies and nations cope with the epidemic. But that can only happen if troubling issues of cost and practicality can be surmounted.
These guidelines for the treatment of persons who have or are at risk for sexually transmitted diseases (STDs) were updated by CDC after consultation with a group of professionals knowledgeable in the field of STDs. The information in this report updates the 2006 Guidelines for Treatment of Sexually Transmitted Diseases (MMWR 2006;55[No. RR–11]).